RE: RE: trendisnotafriendI'll agree with you that in the past there have been many times the SP went up greatly before the news to only go down after. Still the last two releases did not see the same kind of bump up. Most of the major tests are done and now we are just getting the tail end tests or expanded ones that we already know should follow previous tests. The Trend now seems to be flat even with news. Only some kind of out of water statement or news could give it the NCI kind of bump.
Note Toxicology test have already been released in the small scale test for mice with OHRI and that is the test that has been expanded from 21 or 22 mice to over 200. Human cell test may have started or will be starting up in the fall but I have not seen a news release to confirm this. Sloan has moved to mice now for testing but no confirmation on when the tests actually commenced. NRC and Tandem have continue testing but likely results are not comming till mid-fall if they have already started. There are probably more stuff going on in the background but until they are hard facts I don't think the company will issue any release on them or tell us in a NR they are in testing.
I am still wondering if there was any significance to Dr. Sokoll starting on September 1st as the VP and COO instead of taking it over immediately. Is it just that he had to give notice to his previous employer (if applicable) time to transition or just wanted to leave the rest of the summer off. It probably is nothing but could be fun to think about if we get really bored here waiting for the next set of test or that miracle NR about a license deal.